S1 guidelines for the management of postviral conditions using the example of post-COVID-19
© 2023. The Author(s)..
These S1 guidelines are an updated and expanded version of the S1 guidelines on long COVID differential diagnostic and management strategies. They summarize the state of knowledge on postviral conditions like long/post COVID at the time of writing. Due to the dynamic nature of knowledge development, they are intended to be "living guidelines". The focus is on practical applicability at the level of primary care, which is understood to be the appropriate place for initial access and for primary care and treatment. The guidelines provide recommendations on the course of treatment, differential diagnostics of the most common symptoms that can result from infections like with SARS-CoV-2, treatment options, patient management and care, reintegration and rehabilitation. The guidelines have been developed through an interdisciplinary and interprofessional process and provide recommendations on interfaces and possibilities for collaboration.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:135 |
|---|---|
| Enthalten in: |
Wiener klinische Wochenschrift - 135(2023), Suppl 4 vom: 08. Juli, Seite 525-598 |
| Sprache: |
Deutsch |
|---|
| Weiterer Titel: |
Leitlinie S1 für das Management postviraler Zustände am Beispiel Post-COVID-19 |
|---|
| Beteiligte Personen: |
Rabady, Susanne [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
English Abstract |
|---|
| Anmerkungen: |
Date Completed 18.09.2023 Date Revised 10.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00508-023-02242-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM360555217 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM360555217 | ||
| 003 | DE-627 | ||
| 005 | 20240114233341.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1007/s00508-023-02242-z |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1255.xml |
| 035 | |a (DE-627)NLM360555217 | ||
| 035 | |a (NLM)37555900 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ger | ||
| 100 | 1 | |a Rabady, Susanne |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a S1 guidelines for the management of postviral conditions using the example of post-COVID-19 |
| 246 | 3 | 3 | |a Leitlinie S1 für das Management postviraler Zustände am Beispiel Post-COVID-19 |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.09.2023 | ||
| 500 | |a Date Revised 10.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s). | ||
| 520 | |a These S1 guidelines are an updated and expanded version of the S1 guidelines on long COVID differential diagnostic and management strategies. They summarize the state of knowledge on postviral conditions like long/post COVID at the time of writing. Due to the dynamic nature of knowledge development, they are intended to be "living guidelines". The focus is on practical applicability at the level of primary care, which is understood to be the appropriate place for initial access and for primary care and treatment. The guidelines provide recommendations on the course of treatment, differential diagnostics of the most common symptoms that can result from infections like with SARS-CoV-2, treatment options, patient management and care, reintegration and rehabilitation. The guidelines have been developed through an interdisciplinary and interprofessional process and provide recommendations on interfaces and possibilities for collaboration | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Infectious diseases | |
| 650 | 4 | |a Long term consequences | |
| 650 | 4 | |a Long term sequelae | |
| 650 | 4 | |a Persisting symptoms | |
| 650 | 4 | |a Post-infectious condition | |
| 700 | 1 | |a Hoffmann, Kathryn |e verfasserin |4 aut | |
| 700 | 1 | |a Aigner, Martin |e verfasserin |4 aut | |
| 700 | 1 | |a Altenberger, Johann |e verfasserin |4 aut | |
| 700 | 1 | |a Brose, Markus |e verfasserin |4 aut | |
| 700 | 1 | |a Costa, Ursula |e verfasserin |4 aut | |
| 700 | 1 | |a Denk-Linnert, Doris-Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Gruber, Samuel |e verfasserin |4 aut | |
| 700 | 1 | |a Götzinger, Florian |e verfasserin |4 aut | |
| 700 | 1 | |a Helbok, Raimund |e verfasserin |4 aut | |
| 700 | 1 | |a Hüfner, Katharina |e verfasserin |4 aut | |
| 700 | 1 | |a Koczulla, Rembert |e verfasserin |4 aut | |
| 700 | 1 | |a Kurz, Katharina |e verfasserin |4 aut | |
| 700 | 1 | |a Lamprecht, Bernd |e verfasserin |4 aut | |
| 700 | 1 | |a Leis, Stefan |e verfasserin |4 aut | |
| 700 | 1 | |a Löffler, Judith |e verfasserin |4 aut | |
| 700 | 1 | |a Müller, Christian A |e verfasserin |4 aut | |
| 700 | 1 | |a Rittmannsberger, Hans |e verfasserin |4 aut | |
| 700 | 1 | |a Rommer, Paulus S |e verfasserin |4 aut | |
| 700 | 1 | |a Sator, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Strenger, Volker |e verfasserin |4 aut | |
| 700 | 1 | |a Struhal, Walter |e verfasserin |4 aut | |
| 700 | 1 | |a Untersmayr, Eva |e verfasserin |4 aut | |
| 700 | 1 | |a Vonbank, Karin |e verfasserin |4 aut | |
| 700 | 1 | |a Wancata, Johannes |e verfasserin |4 aut | |
| 700 | 1 | |a Weber, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Wendler, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Zwick, Ralf-Harun |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Wiener klinische Wochenschrift |d 1946 |g 135(2023), Suppl 4 vom: 08. Juli, Seite 525-598 |w (DE-627)NLM000045071 |x 1613-7671 |7 nnns |
| 773 | 1 | 8 | |g volume:135 |g year:2023 |g number:Suppl 4 |g day:08 |g month:07 |g pages:525-598 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00508-023-02242-z |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 135 |j 2023 |e Suppl 4 |b 08 |c 07 |h 525-598 | ||